<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04894747</url>
  </required_header>
  <id_info>
    <org_study_id>200325_B_04UOE</org_study_id>
    <nct_id>NCT04894747</nct_id>
  </id_info>
  <brief_title>Mycoprotein and Pea Protein Blend and Muscle Protein Synthetic Response</brief_title>
  <acronym>BPM</acronym>
  <official_title>Comparing Postprandial Muscle Protein Synthesis Rates Following the Consumption of Mycoprotein, Pea Protein and a Mycoprotein/Pea Protein Blend in Resistance Trained Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Exeter</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Quorn</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Exeter</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dietary protein is vital for the preservation of health and optimal adaptation to training.&#xD;
      Plant proteins are considered inferior to animal proteins with respect to their ability to&#xD;
      stimulate an acute muscle building response and therefore support long-term muscle&#xD;
      reconditioning. Pea protein is a highly commercially available plant proteins source&#xD;
      (available as supplements, food ingredients etc.), yet there is no research investigating its&#xD;
      ability to stimulate a muscle building response. The investigators aim to assess the effect&#xD;
      of consuming pea protein on muscle protein synthesis rates and compare these results to&#xD;
      mycoprotein, a source known to elicit a robust anabolic response.&#xD;
&#xD;
      Pea protein is lower in some of the essential amino acids, namely methionine, which could&#xD;
      mean it is less effective compared with mycoprotein which has a more complete amino acid&#xD;
      profile. So in addition to comparing pea with mycoprotein, the investigators also want to&#xD;
      compare to a blend of pea and mycoprotein to see if replenishing the amino acid content in&#xD;
      pea 'rescues' the anabolic response. In this study, the investigators will be using two types&#xD;
      of blends to assess whether the process by which a protein source is produced effects the&#xD;
      muscle building response.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle protein synthesis</measure>
    <time_frame>8.5 hours</time_frame>
    <description>The rate of synthesis of new muscle protein (Fractional synthetic rate %/h)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma amino acid kinetics</measure>
    <time_frame>8.5 hours</time_frame>
    <description>The appearance of amino acids from the protein drink in the circulation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum insulin concentrations</measure>
    <time_frame>8.5 hours</time_frame>
    <description>Basal and postprandial concentrations of serum insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Translocation of mTOR via immunohistochemistry</measure>
    <time_frame>8.5 hours</time_frame>
    <description>Locality of mTOR within the muscle cell</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mTOR phosphorylation via ATP kinase assay</measure>
    <time_frame>8.5 hours</time_frame>
    <description>The amount of mTOR that has been activated in the muscle cell</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Muscle Protein Synthesis</condition>
  <arm_group>
    <arm_group_label>Mycoprotein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bolus ingestion of mycoprotein providing 25g of protein.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pea protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bolus ingestion of pea protein providing 25g of protein.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mycoprotein/pea protein dry blend</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bolus ingestion of mycoprotein/pea protein dry blend providing 25g of protein.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bolus ingestion of mycoprotein/pea protein extrudate blend</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bolus ingestion of mycoprotein/pea protein extrudate blend providing 25g of protein.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bolus ingestion of protein</intervention_name>
    <description>Ingestion of 25g of protein</description>
    <arm_group_label>Bolus ingestion of mycoprotein/pea protein extrudate blend</arm_group_label>
    <arm_group_label>Mycoprotein</arm_group_label>
    <arm_group_label>Mycoprotein/pea protein dry blend</arm_group_label>
    <arm_group_label>Pea protein</arm_group_label>
    <other_name>Protein ingestion</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI between 18 and 30&#xD;
&#xD;
          -  Resistance trained&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any metabolic impairment&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Use of over the counter pharmaceuticals (excluding oral contraceptives and&#xD;
             contraceptive devices).&#xD;
&#xD;
          -  A personal family history of epilepsy, seizures or schizophrenia.&#xD;
&#xD;
          -  Allergic to Quorn/mycoprotein/edible fungi/environmental mould products.&#xD;
&#xD;
          -  Any motor disorder.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sam West, MSc</last_name>
    <phone>+441392724774</phone>
    <email>sw527@exeter.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Benjamin Wall, PhD</last_name>
    <phone>+441392724774</phone>
    <email>B.T.Wall@exeter.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Exeter</name>
      <address>
        <city>Exeter</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sam West, MSc</last_name>
      <phone>+441392724774</phone>
      <email>sw527@exeter.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Benjamin Wall, PhD</last_name>
      <phone>+441392724774</phone>
      <email>B.T.Wall@exeter.ac.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Sam West, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin Wall, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 5, 2021</study_first_submitted>
  <study_first_submitted_qc>May 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2021</study_first_posted>
  <last_update_submitted>May 19, 2021</last_update_submitted>
  <last_update_submitted_qc>May 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

